Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$233.37 USD
+3.62 (1.58%)
Updated Feb 3, 2023 04:00 PM ET
After-Market: $233.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/23/2023
Time: BMO |
12/2022 | $-2.13 | 2.44% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of -$3.32 per share, missing the Zacks Consensus Estimate of -$1.86 per share. This reflects a negative earnings surprise of 78.49%. Look out for ALNY's next earnings release on February 23, 2023. For the next earning release, we expect the company to report earnings of -$2.13 per share, reflecting a year-over-year increase of 1.39%.
Earnings History
Price & Consensus
Zacks News for ALNY
Is Nuveen ESG MidCap Growth ETF (NUMG) a Strong ETF Right Now?
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services